Stock Markets Analysis & Opinion

There is no mystery behind investors’ hunt for stocks with estimate beating potential ahead of an earnings season. This is because investors always try to place themselves ahead of time and look...

DAX holds support at 13060/040 as expected but longs need stops below 13000. A break lower risks a slide to 12990/980, perhaps as far as 12900/890. Below targets 12850/840 before the 12806...

Euro Stoxx 50 minor support at 3559/55. Below 3550 targets 3532/28 before a buying opportunity at 3510/05. Try longs with stops below 3485. It's a major level so we need a wide stop but therefore a...

FTSE minor support at 7478/74 then better support at 7458/54. On further losses look for 7440 before a buying opportunity at 7425/20. A break above yesterday's high at 7511 targets 7520 & 7530/33...

The latest Fed assembly marked the second to the farewell meeting of Janet L. Yellen, who took office as Chair of the Board of Governors of the Federal Reserve on Feb 3, 2014. Her four-year term will...

On Thursday, members of the Federal Communications Commission voted to overturn Obama-era net neutrality rules in a controversial decision that threatens to change the way Americans purchase and...

Thursday, December 14, 2017The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft...

As widely expected, the Fed effected the third-rate hike of the year in its December meeting. The Fed raised the benchmark interest rates by a modest 25 bps to 1.25-1.50%, confirming the U.S....

U.S. stock markets are now hitting all-time highs on a daily basis. Stocks have mostly rallied since last year’s election, with a booming U.S. economy, supportive monetary policy and robust...

Ryan McQueeny makes his first ever appearance on Bolan’s Blowouts and Brian was the first one to note that he made this video a blowout success. Brian and Ryan take a look at SeaChange (SEAC)...

Pfizer Inc. (NYSE:PFE) announced that the FDA has approved Ixifi its second biosimilar version of Johnson & Johnson's (NYSE:JNJ) blockbuster rheumatoid arthritis (“RA”) drug,...

Unprecedented catastrophe loss weighed on RenaissanceRe Holdings Ltd. (NYSE:RNR) this year, thanks to Mother Nature’s fury that took a toll on the company’s underwriting performance. As...

Symantec Corporation (NASDAQ:SYMC) recently announced that the principal components of its Integrated Cyber Defense platform are now accessible through Oracle (NYSE:ORCL) Cloud Marketplace....

The U.S. telecom industry remained rather subdued last week. Nevertheless, a few developments are worth taking note of.Verizon Communications Inc. (NYSE:VZ) has inked a five-year digital streaming...